CSPHF
Price
$0.52
Change
+$0.24 (+85.71%)
Updated
Feb 27 closing price
Capitalization
379.14M
NBTX
Price
$3.18
Change
+$0.01 (+0.32%)
Updated
Apr 10 closing price
Capitalization
156.51M
33 days until earnings call
Ad is loading...

CSPHF vs NBTX

Header iconCSPHF vs NBTX Comparison
Open Charts CSPHF vs NBTXBanner chart's image
CSTONE PHARMACEUTICALS
Price$0.52
Change+$0.24 (+85.71%)
Volume$5K
Capitalization379.14M
Nanobiotix SA
Price$3.18
Change+$0.01 (+0.32%)
Volume$802
Capitalization156.51M
CSPHF vs NBTX Comparison Chart
Loading...
NBTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSPHF vs. NBTX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSPHF is a Hold and NBTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 11, 2025
Stock price -- (CSPHF: $0.52 vs. NBTX: $3.18)
Brand notoriety: CSPHF and NBTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSPHF: 144% vs. NBTX: 7%
Market capitalization -- CSPHF: $379.14M vs. NBTX: $156.51M
CSPHF [@Biotechnology] is valued at $379.14M. NBTX’s [@Biotechnology] market capitalization is $156.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $122.24B to $0. The average market capitalization across the [@Biotechnology] industry is $1.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSPHF’s FA Score shows that 0 FA rating(s) are green whileNBTX’s FA Score has 0 green FA rating(s).

  • CSPHF’s FA Score: 0 green, 5 red.
  • NBTX’s FA Score: 0 green, 5 red.
According to our system of comparison, CSPHF is a better buy in the long-term than NBTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NBTX’s TA Score shows that 3 TA indicator(s) are bullish.

  • NBTX’s TA Score: 3 bullish, 6 bearish.

Price Growth

CSPHF (@Biotechnology) experienced а 0.00% price change this week, while NBTX (@Biotechnology) price change was -5.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.33%. For the same industry, the average monthly price growth was -17.76%, and the average quarterly price growth was -19.66%.

Reported Earning Dates

NBTX is expected to report earnings on Sep 04, 2025.

Industries' Descriptions

@Biotechnology (-7.33% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSPHF($379M) has a higher market cap than NBTX($157M). CSPHF YTD gains are higher at: 129.756 vs. NBTX (10.718).
CSPHFNBTXCSPHF / NBTX
Capitalization379M157M241%
EBITDAN/AN/A-
Gain YTD129.75610.7181,211%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
NBTX
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 14 days ago
72%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
NBTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSAAX14.95N/A
N/A
Fidelity Advisor Asset Manager 60% A
THORX35.84N/A
N/A
Thornburg Global Opportunities R3
TMIRX8.73N/A
N/A
Transamerica Mid Cap Growth R
TIHIX11.82N/A
N/A
Transamerica International Stock I2
VDMCX8.67N/A
N/A
Virtus KAR Developing Markets C

CSPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSPHF has been loosely correlated with DVHGF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CSPHF jumps, then DVHGF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSPHF
1D Price
Change %
CSPHF100%
N/A
DVHGF - CSPHF
38%
Loosely correlated
N/A
WINT - CSPHF
24%
Poorly correlated
+2.15%
BCAB - CSPHF
9%
Poorly correlated
+12.94%
SIGY - CSPHF
8%
Poorly correlated
N/A
NBTX - CSPHF
7%
Poorly correlated
+4.97%
More

NBTX and

Correlation & Price change

A.I.dvisor tells us that NBTX and PBYI have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NBTX and PBYI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBTX
1D Price
Change %
NBTX100%
+0.24%
PBYI - NBTX
28%
Poorly correlated
-5.84%
GLMD - NBTX
26%
Poorly correlated
-11.27%
CRMD - NBTX
25%
Poorly correlated
-2.29%
GLPG - NBTX
24%
Poorly correlated
-2.30%
OTLK - NBTX
23%
Poorly correlated
+3.33%
More